Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Bone marrow mesenchymal stem cells tune the differentiation of myeloid-derived suppressor cells in bleomycin-induced lung injury

Fig. 2

Phenotype of Gr-1+CD11b+ cells. After BMSC treatment in BLM-treated mice, Gr-1+CD11b+ cells in the right lungs of sham-, BLM-, and BMSC-treated mice were analyzed for expression of various surface markers. a Representative flow cytometry data on day 7 and 28. b Expression of indicated markers by Gr-1+CD11b+ cells in the lungs of sham-, BLM-, and BMSC-treated mice (six mice per group). Data presented are representative of three replicated experiments. *P < 0.01 and †P < 0.05 as compared with the BMSC group; and #P < 0.01 and ‡P < 0.05 as compared with the sham group. BLM bleomycin, BMSC bone marrow mesenchymal stem cells

Back to article page